Hong Kong Sanatorium & Hospital, or HKSH, is a private hospital established in 1922 in Happy Valley, Hong Kong. The hospital has more than 500 beds and various room types and facilities. It also has a 24 hours outpatient consultation service.

There are 480 beds in Hong Kong Sanatorium & Hospital.

During the past decade, Hong Kong Sanatorium & Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hong Kong Sanatorium & Hospital" #1 sponsor was "Hong Kong Sanatorium & Hospital" with 6 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Broncus Medical Inc" with 1 trials sponsored and "The University of Hong Kong" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hong Kong Sanatorium & Hospital" #1 collaborator was "Chinese University of Hong Kong" with 2 trials as a collaborator and "Stanford University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hong Kong Sanatorium & Hospital" are "Allergy to Crab" (1 trials), "Allergy to Fish" (1 trials), "Allergy to Shrimp" (1 trials), "Anaphylaxis" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Hong Kong Sanatorium & Hospital" in a lesser frequency.

Most popular intervention types in "Hong Kong Sanatorium & Hospital" are "Biological" (3 trials), "Drug" (3 trials), "Diagnostic Test" (2 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Archimedes System" (1 trials), "Azacitidine" (1 trials), "BNT162b2 Vaccine" (1 trials) and "COVID 19 Diagnostic Test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hong Kong Sanatorium & Hospital" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hong Kong Sanatorium & Hospital". 1 are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hong Kong Sanatorium & Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hong Kong Sanatorium & Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".